Chiara Elia graduated in Medical Pharmaceutical Biotechnology in 2011 and received her PhD in Pharmacological Sciences in 2016 at University of Milan. She joined Matteoli Group in 2012. Her work is focused on Extracellular Vesicles molecular mechanisms and biological effects involved in Alzheimer Disease and Stroke.